A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis

Hepatic fibrosis

Clinical Trial for Evaluation of Treatment With Multiple Infusions of Mononuclear Bone Marrow Cells in Patients With Chronic Liver Diseases A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis A Study of Experimental Medication BMS-986036 Given to Healthy Participants Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus With Standard Treatment Human Umbilical Cord-Mesenchymal Stem Cells for Hepatic Cirrhosis A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV Prediction of Hepatic Fibrosis in Patients With Chronic Hepatitis C by Biochemical and Duplex Doppler Indices Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD Development of an Imaging Biomarker for Hepatic Fibrosis Using Gadoxetate Disodium Prediction of Significant Hepatic Fibrosis in HCV Carriers With PNALT by SAPI- A Validation Study A Study of Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C Magnetic Resonance Elastography (MRE) as a Predictor of HCC Recurrence After Radiofrequency Ablation (RFA) Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study